+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hepatitis Test Solution/Diagnosis Market by Technology, Product Type, End User, Test Type, Application - Global Forecast to 2030- Product Image
Hepatitis Test Solution/Diagnosis Market by Technology, Product Type, End User, Test Type, Application - Global Forecast to 2030- Product Image
Sale

Hepatitis Test Solution/Diagnosis Market by Technology, Product Type, End User, Test Type, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904514
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Hepatitis Test Solution/Diagnosis Market is at a critical juncture, with global healthcare trends accelerating the need for innovative, timely, and decentralized hepatitis testing. Demand for accurate diagnostics is intensifying, driven by technological advancements, changing regulatory landscapes, and a growing focus on patient-centric care models.

Market Snapshot: Hepatitis Test Solution/Diagnosis Market Overview

The Hepatitis Test Solution/Diagnosis Market grew from USD 3.71 billion in 2024 to USD 3.92 billion in 2025. It is expected to continue growing at a CAGR of 5.57%, reaching USD 5.13 billion by 2030. The adoption of advanced diagnostic platforms and increased investment in public health initiatives are key contributors, while the rise of decentralized testing and new reimbursement frameworks shape the competitive landscape.

Scope & Segmentation

This report provides a deep analysis of the hepatitis diagnostics market by outlining key segments, product categories, user groups, and geographic coverage:

  • Technology: Chromatography (including FIA and HPLC), Immunoassay (Chemiluminescent Immunoassays, ELISA, Rapid Immunoassays), and Molecular Diagnostics (Isothermal Amplification, PCR, Real-Time PCR).
  • Product Type: Bench-Top Instruments, High-Throughput Instruments, Kits & Reagents (Chromatography Kits, Immunoassay Kits, Molecular Assay Kits), as well as Software & Services.
  • End User: Blood Banks, Clinics, Diagnostic Laboratories (Hospital-Based and Independent), Home Care Settings, General Hospitals, and Specialized Hospitals.
  • Test Type: Confirmatory Tests (ELISA Confirmatory, PCR Confirmatory) and Screening Tests.
  • Application: Clinical Diagnostics and Research.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including major markets such as United Kingdom, Germany, France, United Arab Emirates, and South Africa), and Asia-Pacific (notably China, India, Japan, Australia, and several others).
  • Key Companies Addressed: Roche Diagnostics International AG, Abbott Laboratories, Siemens Healthineers AG, bioMérieux SA, Ortho Clinical Diagnostics, Becton, Dickinson and Company, DiaSorin S.p.A., QIAGEN N.V., Fujirebio, Inc., and Danaher Corporation.

Key Takeaways

  • Technological convergence, including high-sensitivity analyses and integrated platforms, supports more accurate and rapid hepatitis detection across diverse healthcare environments.
  • Public health initiatives and evolving reimbursement paradigms are motivating widespread adoption of point-of-care and home-based testing, driving decentralization and greater accessibility.
  • Modular system design and supply chain agility allow market participants to respond promptly to shifts in global policies, regulatory changes, and unexpected disruptions.
  • Collaboration between manufacturers, reagent suppliers, and technology firms is strengthening product innovation and operational workflow efficiency.
  • Manufacturers are enhancing regional presence through acquisitions and service centers, which supports improved lead times and customer responsiveness in high-growth markets.

Tariff Impact on Supply Chain Strategy

The imposition of 2025 United States tariffs on imported laboratory components has influenced sourcing and manufacturing strategies across this market. Companies are adjusting logistics and nearshoring capabilities to address input cost volatility. Diagnostic providers are optimizing test portfolios and engaging in bundled agreements to maintain affordability, while industry consortia work to streamline regulatory approvals for alternative suppliers and safeguard uninterrupted testing access.

Methodology & Data Sources

Findings are grounded in comprehensive secondary research, proprietary interviews with industry stakeholders, and triangulation with quantitative sales and usage data. Validation workshops with independent experts and iterative peer reviews ensure the credibility and neutrality of the insights presented.

Why This Report Matters

  • Enables strategic planning by equipping senior decision-makers with actionable insights into technology, regional dynamics, and supply chain adjustments in hepatitis testing.
  • Provides a structured, unbiased foundation for evaluating partnerships, investment decisions, and market entry or expansion strategies within the hepatitis diagnostics sector.

Conclusion

The Hepatitis Test Solution/Diagnosis Market is moving toward integrated, decentralized, and data-driven diagnostics. Prioritizing technological advancement, operational agility, and collaborative frameworks positions stakeholders to address future opportunities and challenges.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hepatitis Test Solution/Diagnosis Market, by Technology
8.1. Introduction
8.2. Chromatography
8.2.1. Fia
8.2.2. Hplc
8.3. Immunoassay
8.3.1. Chemiluminescent Immunoassays
8.3.2. Elisa
8.3.3. Rapid Immunoassays
8.4. Molecular Diagnostics
8.4.1. Isothermal Amplification
8.4.2. Pcr
8.4.3. Real-Time Pcr
9. Hepatitis Test Solution/Diagnosis Market, by Product Type
9.1. Introduction
9.2. Instruments
9.2.1. Bench-Top Instruments
9.2.2. High-Throughput Instruments
9.3. Kits & Reagents
9.3.1. Chromatography Kits
9.3.2. Immunoassay Kits
9.3.3. Molecular Assay Kits
9.4. Software & Services
10. Hepatitis Test Solution/Diagnosis Market, by End User
10.1. Introduction
10.2. Blood Banks
10.3. Clinics
10.4. Diagnostic Laboratories
10.4.1. Hospital-Based Laboratories
10.4.2. Independent Laboratories
10.5. Home Care Settings
10.6. Hospitals
10.6.1. General Hospitals
10.6.2. Specialized Hospitals
11. Hepatitis Test Solution/Diagnosis Market, by Test Type
11.1. Introduction
11.2. Confirmatory Tests
11.2.1. Elisa Confirmatory
11.2.2. Pcr Confirmatory
11.3. Screening Tests
12. Hepatitis Test Solution/Diagnosis Market, by Application
12.1. Introduction
12.2. Clinical Diagnostics
12.3. Research
13. Americas Hepatitis Test Solution/Diagnosis Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Hepatitis Test Solution/Diagnosis Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Hepatitis Test Solution/Diagnosis Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Roche Diagnostics International AG
16.3.2. Abbott Laboratories
16.3.3. Siemens Healthineers AG
16.3.4. bioMérieux SA
16.3.5. Ortho Clinical Diagnostics, Inc.
16.3.6. Becton, Dickinson and Company
16.3.7. DiaSorin S.p.A.
16.3.8. QIAGEN N.V.
16.3.9. Fujirebio, Inc.
16.3.10. Danaher Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET MULTI-CURRENCY
FIGURE 2. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET MULTI-LANGUAGE
FIGURE 3. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY FIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HPLC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BENCH-TOP INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HIGH-THROUGHPUT INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SPECIALIZED HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ELISA CONFIRMATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PCR CONFIRMATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SCREENING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 81. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 83. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 84. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 85. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 87. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 88. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 90. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 91. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 92. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 93. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 97. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 98. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 99. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 101. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 103. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 105. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 162. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 163. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 164. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 166. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 167. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 169. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 170. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 171. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 172. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 175. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 176. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 177. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 179. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 180. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 182. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 183. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 184. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 185. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 201. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 202. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 203. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 205. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 206. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 208. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 209. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 210. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 211. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 214. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 215. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 216. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 218. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 219. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 221. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 223. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 224. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 266. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 267. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 268. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 270. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 271. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 273. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 274. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 275. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 276. DENMARK HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. QATAR HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. QATAR HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
TABLE 292. QATAR HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 293. QATAR HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 294. QATAR HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. QATAR HEPATITIS TEST SOL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Hepatitis Test Solution/Diagnosis market report include:
  • Roche Diagnostics International AG
  • Abbott Laboratories
  • Siemens Healthineers AG
  • bioMérieux SA
  • Ortho Clinical Diagnostics, Inc.
  • Becton, Dickinson and Company
  • DiaSorin S.p.A.
  • QIAGEN N.V.
  • Fujirebio, Inc.
  • Danaher Corporation

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.13 Billion
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Global Hepatitis Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Hepatitis Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • Global
From
Hepatitis Test Solution/Diagnosis - Global Strategic Business Report - Product Image

Hepatitis Test Solution/Diagnosis - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From
Hepatitis Diagnostic Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Hepatitis Diagnostic Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Hepatitis Diagnostic Tests Market Report 2025 - Product Image

Hepatitis Diagnostic Tests Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Hepatitis B and C Diagnostics Market 2024-2028 - Product Image

Hepatitis B and C Diagnostics Market 2024-2028

  • Report
  • 176 Pages
  • Global
From

About the Hepatitis Test Solution Diagnosis Market

In the realm of infectious disease testing, the hepatitis test solution diagnosis market comprises a segment focused on detecting and quantifying the presence of hepatitis infections, which include Hepatitis A, B, C, D, and E. Diagnosis of these conditions is critical due to their impact on liver function and potential for causing liver disease, cirrhosis, or carcinoma. The market includes a variety of testing modalities such as immunoassay-based tests, PCR-based tests, and point-of-care testing platforms. These diagnostic tools help in screening blood donations, monitoring the disease, and managing treatment regimens for infected patients. Advances in biotechnology have led to the development of more rapid and sensitive tests, facilitating early detection and improved patient outcomes. Numerous enterprises partake in the hepatitis test solution diagnosis market. Some notable companies include Abbott Laboratories, known for their range of immunoassays and laboratory equipment; Roche Diagnostics, offering advanced molecular assays; Siemens Healthineers, providing a comprehensive suite of diagnostic solutions; and QIAGEN, which supplies technologies for nucleic acid amplification testing. Additionally, Bio-Rad Laboratories and Beckman Coulter offer a variety of testing reagents and instruments that support hepatitis diagnosis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.